Selected publications
-
Prevalence and management of iron overload in pyruvate kinase deficiency: report from the Pyruvate Kinase Deficiency Natural History Study.
Haematologica.
2019
Information Resource
GET IT
Times cited: 3 -
Second-line treatments in children with immune thrombocytopenia: Effect on platelet count and patient-centered outcomes.
American Journal of Hematology.
2019
Academic Article
GET IT
Times cited: 4 -
IVIg and FcgRIIb in kids with ITP: Individualizing therapy.
Blood.
2018
Academic Article
GET IT
Times cited: 2 -
Clinical spectrum of pyruvate kinase deficiency: Data from the pyruvate kinase deficiency natural history study.
Blood.
2018
Academic Article
GET IT
Times cited: 17 -
Physician decision making in selection of second-line treatments in immune thrombocytopenia in children.
American Journal of Hematology.
2018
Academic Article
GET IT
Times cited: 7 -
Eltrombopag for the treatment of children with persistent and chronic immune thrombocytopenia (PETIT): A randomised, multicentre, placebo-controlled study.
The Lancet Haematology.
2015
Academic Article
GET IT
Times cited: 79